Drug Candidate Reduced Brain Inflammation and Protected Against Cognitive Decline in Alzheimer’s Mouse Model - Neuroscience News
3/2/2022 12:00:00 AM3 years 11 months ago
by https://www.facebook.com/neurosciencenews
by https://www.facebook.com/neurosciencenews
3,6’-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer's disease against cognitive decline by reducing neuroinflammation.
Summary: 3,6-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer’s disease against cognitive decline by reducing neuroinflammation. Source: NIH An anti… [+3262 chars]
full article...